Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Transplant Technology

Apheresis product identification in the transplant center: development of point-of-care protocols for extended blood typing of stem cell apheresis products

Abstract

Transfusion of the ‘wrong’ stem cell product would almost inevitably be lethal, yet assays to confirm the contents of the product bag, except by checking labels and paperwork, are lacking. To increase the likelihood that a product mix-up would be detected in the transplant center, we developed a simple protocol for extended blood typing and hence, for confirmation of donor/product identity, on a tube segment. Apheresis samples were applied, directly or after erythrocyte enrichment, to commercially available blood typing assays, including lateral flow cards and gel agglutination cards. Without sample modification, low hematocrit and high leukocyte count obviated definitive blood typing. Using the most simple erythrocyte enrichment protocol, that is, centrifugation, reliable blood group analysis became possible with either assay. Other, more cumbersome pre-analytical protocols were also successful but provided no advantage. The preferred method was validated on 100 samples; ABD was correctly identified in 100% of cases. Of the other Rh Ags, all except two ‘small e’, in both cases in heterozygous individuals, were detected; there were no false positives. A simple, inexpensive point-of-care assay for extended blood typing of apheresis products is available, which can reduce the fatal risk of administering the wrong stem cell product.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Warkentin PI, Nick L, Shpall EJ . Hematopoietic cell procurement, processing and transplantation: regulation and accreditation. In: Appelbaum FR, Forman SJ, Negrin RS, Blume KG (eds). Thomas' Hematopoietic Cell Transplantation, 4th edn. Wiley-Blackwell: Hobokoen, NJ, USA, 2011.

    Google Scholar 

  2. Foeken LM, Green A, Hurley CK, Marry E, Wiegand T, Oudshoorn M . Monitoring the international use of unrelated donors for transplantation: the WMDA annual reports. Bone Marrow Transplant 2010; 45: 811–818.

    Article  CAS  Google Scholar 

  3. Cohen H . SHOT 2009 Annual Report Summary. http://www.shotuk.org/wp-content/uploads/2010/07/SHOT-2009.pdf-Summary.pdf 2011 May 23 (cited 23 May 2011).

  4. McCullough J, McKenna D, Kadidlo D, Maurer D, Noreen HJ, French K et al. Mislabeled units of umbilical cord blood detected by a quality assurance program at the transplantation center. Blood 2009; 114: 1684–1688.

    Article  CAS  Google Scholar 

  5. Gassner C, Rainer E, Pircher E, Markut L, Kormoczi GF, Jungbauer C et al. Application of a multivariant, caucasian-specific, genotyped donor panel for performance validation of MDmulticard(R), ID-System(R), and Scangel(R) RhD/ABO Serotyping. Transfus Med Hemother 2009; 36: 219–225.

    Article  Google Scholar 

  6. Lapierre Y, Rigal D, Adam J, Josef D, Meyer F, Greber S et al. The gel test: a new way to detect red cell antigen-antibody reactions. Transfusion 1990; 30: 109–113.

    Article  CAS  Google Scholar 

  7. Race RR, Mourant AE . The Rh chromosome frequencies in England. Blood 1948; 3: 689–695.

    CAS  PubMed  Google Scholar 

  8. Mathe G, Schwarzenberg L, Amiel JL, Schneider M, Cattan A, Schlumberger JR et al. Immunogenetic and immunological problems of allogeneic haemopoietic radio-chimaeras in man. Scand J Haematol 1967; 4: 193–216.

    Article  CAS  Google Scholar 

  9. Thomas ED, Epstein RB . Bone marrow transplantation in acute leukemia. Cancer Res 1965; 25: 1521–1524.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The training provided to CC by technicians from the Immunohematology laboratory is gratefully acknowledged.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H Bönig.

Ethics declarations

Competing interests

PS and MS are employees of Medion Grifols Diagnostics, a product of which was used for these studies. None of the other authors have a potential conflict of interest to declare.

Additional information

The data were previously presented in abstract form at the 2010 ISBT annual meeting.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cummerow, C., Schwind, P., Spicher, M. et al. Apheresis product identification in the transplant center: development of point-of-care protocols for extended blood typing of stem cell apheresis products. Bone Marrow Transplant 47, 860–865 (2012). https://doi.org/10.1038/bmt.2011.182

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2011.182

Keywords

This article is cited by

Search

Quick links